We recently published a list of 15 Important AI News and Ratings on Investors’ Radar. In this article, we are going to take a ...

Researchers demonstrated DRAGEN's performance across 3,202 whole-genome sequencing datasets from the 1000 Genomes Project.

The next-generation sequencing market valued at US$ 13.92 billion in 2023, is forecasted to grow at a robust CAGR of 11.0%, ...

Cancer is a disease of the genome, according to Dr. Elli Papaemmanuil, computational oncologist at MSK. By looking at the ...

In 2007, the next-generation sequencing technologies have come into their own with an impressive array of successful applications. Kelly Rae Chi reports. In the toxicology building of North ...

Long read sequencing revealed more genetic information in cases of 42 patients with rare diseases while cutting time and cost of diagnoses.

Visualizing cells after editing specific genes can help scientists learn new details about the function of those genes. But ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the company is developing its first whole-genome ...

Here we describe the generation of large scale single-cell methylation whole genome sequencing cell atlases in pig to human xenotransplants linked to other omics in attempt to generate diagnostic and ...

As part of the partnership, Eurofins Clinical Enterprise will use the DNBSEQ-T7RS™* ("T7"), Complete Genomics' flagship sequencer, to perform whole genome sequencing, low-pass whole genome ...

the G4 Platform enables highly efficient laboratory operations. In this webinar Dr. Timothy Looney will describe the features of the G4 and showcase data from core NGS applications such as whole ...